{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:18:29Z","timestamp":1787674709267,"version":"build-2784847793"},"reference-count":50,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,12,7]],"date-time":"2018-12-07T00:00:00Z","timestamp":1544140800000},"content-version":"vor","delay-in-days":340,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008725","name":"Agencia Nacional de Investigaci\u00f3n e Innovaci\u00f3n","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008725","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Programa de Desarrollo de las Ciencias B\u00e1sicas"},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["303432\/2015-2"],"award-info":[{"award-number":["303432\/2015-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004809","name":"Financiadora de Estudos e Projetos","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SANIMARS","award":["01.10.0783.04"],"award-info":[{"award-number":["01.10.0783.04"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.vaccine.2017.11.030","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T16:46:02Z","timestamp":1511455562000},"page":"55-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines"],"prefix":"10.1016","volume":"36","author":[{"given":"Samuel","family":"Cibulski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Rivera-Patron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norma","family":"Su\u00e1rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Macarena","family":"Pirez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvina","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Carolina","family":"Yendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"de Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Gosmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Fett-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulo Michel","family":"Roehe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.vaccine.2017.11.030_b0005","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/0300985813520250","article-title":"Bovine viral diarrhea virus infections: manifestations of infection and recent advances in understanding pathogenesis and control","volume":"51","author":"Brodersen","year":"2014","journal-title":"Vet Pathol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.11.030_b0010","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1939-1676.2010.0502.x","article-title":"Control of bovine viral diarrhea virus in ruminants","volume":"24","author":"Walz","year":"2010","journal-title":"J Vet Intern Med"},{"key":"10.1016\/j.vaccine.2017.11.030_b0015","series-title":"Bovine viral diarrhea virus: diagnosis, management and control ames","first-page":"65","article-title":"Classification and molecular biology","author":"Ridpath","year":"2005"},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.030_b0020","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1006\/viro.1994.1483","article-title":"Identification of a new group of bovine viral diarrhea virus strains associated with severe outbreaks and high mortalities","volume":"203","author":"Pellerin","year":"1994","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2017.11.030_b0025","series-title":"Virus taxonomy classification and nomenclature of viruses ninth report of the international committee on taxonomy of viruses","first-page":"1010","article-title":"Genus Pestivirus","author":"Simmonds","year":"2012"},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.030_b0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1006\/mcpr.1998.0158","article-title":"Differentiation of types 1a, 1b and 2 bovine viral diarrhoea virus (BVDV) by PCR","volume":"12","author":"Ridpath","year":"1998","journal-title":"Mol Cell Probes"},{"issue":"1","key":"10.1016\/j.vaccine.2017.11.030_b0035","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.cvfa.2003.11.001","article-title":"Evolution of bovine viral diarrhea virus vaccines","volume":"20","author":"Kelling","year":"2004","journal-title":"Vet Clin North Am Food Anim Pract"},{"issue":"3","key":"10.1016\/j.vaccine.2017.11.030_b0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.theriogenology.2014.09.028","article-title":"Efficacy of bovine viral diarrhea virus vaccination to prevent reproductive disease: a meta-analysis","volume":"83","author":"Newcomer","year":"2015","journal-title":"Theriogenology"},{"issue":"1","key":"10.1016\/j.vaccine.2017.11.030_b0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/biol.1994.1004","article-title":"Enzyme-linked immunosorbent assay assessment of bovine viral diarrhea virus antigen in inactivated vaccines using polyclonal or monoclonal antibodies","volume":"22","author":"Ludemann","year":"1994","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.vaccine.2017.11.030_b0050","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1939-1676.2003.tb02448.x","article-title":"Adjuvants in veterinary vaccines: modes of action and adverse effects","volume":"17","author":"Spickler","year":"2003","journal-title":"J Vet Intern Med"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2017.11.030_b0055","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1086\/313883","article-title":"Improving vaccine performance with adjuvants","volume":"30","author":"Vogel","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2017.11.030_b0060","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1007\/s40264-015-0350-4","article-title":"Comparative safety of vaccine adjuvants: a summary of current evidence and future needs","volume":"38","author":"Petrovsky","year":"2015","journal-title":"Drug Saf"},{"issue":"190","key":"10.1016\/j.vaccine.2017.11.030_b0065","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.jconrel.2014.06.027","article-title":"Designing and building the next generation of improved vaccine adjuvants","volume":"28","author":"Brito","year":"2014","journal-title":"J Control Release"},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.030_b0070","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4110\/in.2015.15.2.51","article-title":"Recent advances of vaccine adjuvants for infectious diseases","volume":"15","author":"Lee","year":"2015","journal-title":"Immune Netw"},{"key":"10.1016\/j.vaccine.2017.11.030_b0075","doi-asserted-by":"crossref","unstructured":"Garcon Nathalie HS, Friede M. Evolution of adjuvants across the centuries. In: Saunders, editor. Vaccines. 6th ed. Elsevier, 2013, p. 58\u201370.","DOI":"10.1016\/B978-1-4557-0090-5.00020-3"},{"issue":"38","key":"10.1016\/j.vaccine.2017.11.030_b0080","doi-asserted-by":"crossref","first-page":"6464","DOI":"10.1016\/j.vaccine.2011.07.041","article-title":"Natural products and the search for novel vaccine adjuvants","volume":"29","author":"Rey-Ladino","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2017.11.030_b0085","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1586\/14760584.2014.913483","article-title":"Immunological aspects of using plant cells as delivery vehicles for oral vaccines","volume":"13","author":"Rosales-Mendoza","year":"2014","journal-title":"Expert Rev Vacc"},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.030_b0090","doi-asserted-by":"crossref","first-page":"431","DOI":"10.4049\/jimmunol.146.2.431","article-title":"Separation and characterization of saponins with adjuvant activity from Quillaja saponaria Molina cortex","volume":"146","author":"Kensil","year":"1991","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2017.11.030_b0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF01240612","article-title":"Saponin adjuvants. 3. Isolation of a substance from Quillaja saponaria Molina with adjuvant activity in food-and-mouth disease vaccines","volume":"44","author":"Dalsgaard","year":"1974","journal-title":"Arch Gesamte Virusforsch"},{"issue":"12","key":"10.1016\/j.vaccine.2017.11.030_b0100","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1016\/j.vaccine.2009.01.091","article-title":"Advances in saponin-based adjuvants","volume":"27","author":"Sun","year":"2009","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2017.11.030_b0105","article-title":"QS-21: A potent vaccine adjuvant","volume":"3","author":"Zhu","year":"2016","journal-title":"Nat Prod Chem Res"},{"issue":"Suppl 2","key":"10.1016\/j.vaccine.2017.11.030_b0110","doi-asserted-by":"crossref","first-page":"B14","DOI":"10.1016\/j.vaccine.2015.01.088","article-title":"New generation adjuvants\u2013from empiricism to rational design","volume":"33","author":"O'Hagan","year":"2015","journal-title":"Vaccine"},{"issue":"49","key":"10.1016\/j.vaccine.2017.11.030_b0115","doi-asserted-by":"crossref","first-page":"9177","DOI":"10.1016\/j.vaccine.2011.09.137","article-title":"Quillaja brasiliensis saponins are less toxic than Quil A and have similar properties when used as an adjuvant for a viral antigen preparation","volume":"29","author":"Silveira","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"10.1016\/j.vaccine.2017.11.030_b0120","doi-asserted-by":"crossref","first-page":"e105374","DOI":"10.1371\/journal.pone.0105374","article-title":"Alternative inactivated poliovirus vaccines adjuvanted with Quillaja brasiliensis or Quil-a saponins are equally effective in inducing specific immune responses","volume":"9","author":"De Costa","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.030_b0125","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/cyto.1996.0139","article-title":"Immunomodulation by Quillaja saponaria adjuvant formulations: in vivo stimulation of interleukin 12 and its effects on the antibody response","volume":"9","author":"Villacres-Eriksson","year":"1997","journal-title":"Cytokine"},{"issue":"20","key":"10.1016\/j.vaccine.2017.11.030_b0130","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.vaccine.2016.03.070","article-title":"A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge","volume":"34","author":"Yendo","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2017.11.030_b0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cimid.2016.01.004","article-title":"Quillaja brasiliensis saponins induce robust humoral and cellular responses in a bovine viral diarrhea virus vaccine in mice","volume":"45","author":"Cibulski","year":"2016","journal-title":"Comp Immunol Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2017.11.030_b0140","doi-asserted-by":"crossref","unstructured":"Yendo AC, de Costa F, Kauffmann C, Fleck JD, Gosmann G, Fett-Neto AG. Purification of an immunoadjuvant saponin fraction from quillaja brasiliensis leaves by reversed-phase silica gel chromatography. In: Fox CB, editor. Vaccine adjuvants methods and protocols. 2016\/10\/09 ed. New York: Humana Press, 2017, p. 87\u201393.","DOI":"10.1007\/978-1-4939-6445-1_6"},{"issue":"9","key":"10.1016\/j.vaccine.2017.11.030_b0145","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.vaccine.2016.01.029","article-title":"Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake","volume":"34","author":"Cibulski","year":"2016","journal-title":"Vaccine"},{"issue":"49\u201350","key":"10.1016\/j.vaccine.2017.11.030_b0150","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1016\/j.vaccine.2006.06.059","article-title":"Adjuvant activity of Quillaja brasiliensis saponins on the immune responses to bovine herpesvirus type 1 in mice","volume":"24","author":"Fleck","year":"2006","journal-title":"Vaccine"},{"issue":"3\u20134","key":"10.1016\/j.vaccine.2017.11.030_b0155","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF01321060","article-title":"Pestiviruses isolated from pigs, cattle and sheep can be allocated into at least three genogroups using polymerase chain reaction and restriction endonuclease analysis","volume":"136","author":"Vilcek","year":"1994","journal-title":"Arch Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2017.11.030_b0160","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/jmv.1890270406","article-title":"Measurement of avidity of specific IgG for verification of recent primary rubella","volume":"27","author":"Hedman","year":"1989","journal-title":"J Med Virol"},{"issue":"23","key":"10.1016\/j.vaccine.2017.11.030_b0165","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1002\/rcm.1698","article-title":"Metabolomic analysis of saponins in crude extracts of Quillaja saponaria by liquid chromatography\/mass spectrometry for product authentication","volume":"18","author":"Kite","year":"2004","journal-title":"Rapid Commun Mass Spectrom"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2017.11.030_b0170","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0008-6215(99)00134-2","article-title":"Separation and structural analysis of saponins in a bark extract from Quillaja saponaria Molina","volume":"320","author":"Nord","year":"1999","journal-title":"Carbohydr Res"},{"issue":"4","key":"10.1016\/j.vaccine.2017.11.030_b0175","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0008-6215(00)00248-2","article-title":"Novel acetylated triterpenoid saponins in a chromatographic fraction from Quillaja saponaria Molina","volume":"329","author":"Nord","year":"2000","journal-title":"Carbohydr Res"},{"issue":"1","key":"10.1016\/j.vaccine.2017.11.030_b0180","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0031-9422(97)00716-4","article-title":"Triterpenoid saponins from Quillaja saponaria","volume":"48","author":"Guo","year":"1998","journal-title":"Phytochemistry"},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.030_b0185","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1080\/14786410310001608055","article-title":"Constituents from leaves of Quillaja brasiliensis","volume":"18","author":"Kauffmann","year":"2004","journal-title":"Nat Prod Res"},{"key":"10.1016\/j.vaccine.2017.11.030_b0190","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.phytol.2017.04.020","article-title":"Analysis of an immunoadjuvant saponin fraction from Quillaja brasiliensis leaves by electrospray ionization ion trap multiple-stage mass spectrometry","volume":"20","author":"Wallace","year":"2017","journal-title":"Phytochem Lett"},{"issue":"6603","key":"10.1016\/j.vaccine.2017.11.030_b0195","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/383787a0","article-title":"Functional diversity of helper T lymphocytes","volume":"383","author":"Abbas","year":"1996","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.vaccine.2017.11.030_b0200","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol Today"},{"issue":"3","key":"10.1016\/j.vaccine.2017.11.030_b0205","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1074-7613(00)80533-6","article-title":"Cytokines induce the development of functionally heterogeneous T helper cell subsets","volume":"8","author":"O'Garra","year":"1998","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.vaccine.2017.11.030_b0210","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1586\/erv.12.111","article-title":"Do we know the Th1\/Th2\/Th17 determinants of vaccine response?","volume":"11","author":"Garlapati","year":"2012","journal-title":"Expert Rev Vacc"},{"issue":"5","key":"10.1016\/j.vaccine.2017.11.030_b0215","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.285.5.606","article-title":"Prospects for vaccines to protect against AIDS, tuberculosis, and malaria","volume":"285","author":"Letvin","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2017.11.030_b0220","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.coi.2013.12.007","article-title":"Immunomodulatory properties of the vaccine adjuvant alum","volume":"28","author":"Oleszycka","year":"2014","journal-title":"Curr Opin Immunol"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2017.11.030_b0225","first-page":"1","article-title":"Saponins as vaccine adjuvants","volume":"13","author":"Kensil","year":"1996","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"issue":"40","key":"10.1016\/j.vaccine.2017.11.030_b0230","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1016\/j.vaccine.2015.04.099","article-title":"Molecular signatures of vaccine adjuvants","volume":"33","author":"Olafsdottir","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2017.11.030_b0235","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3390\/vaccines2020252","article-title":"Adjuvants in the driver's seat: how magnitude, type, fine specificity and longevity of immune responses are driven by distinct classes of immune potentiators","volume":"2","author":"Bergmann-Leitner","year":"2014","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.vaccine.2017.11.030_b0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2013.11.026","article-title":"Surface plasmon resonance measurements of plasma antibody avidity during primary and secondary responses to anthrax protective antigen","volume":"404","author":"Lynch","year":"2014","journal-title":"J Immunol Methods"},{"issue":"11","key":"10.1016\/j.vaccine.2017.11.030_b0245","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.4049\/jimmunol.138.11.3688","article-title":"Two types of murine helper T cell clone. II. Delayed-type hypersensitivity is mediated by TH1 clones","volume":"138","author":"Cher","year":"1987","journal-title":"J Immunol"},{"issue":"12","key":"10.1016\/j.vaccine.2017.11.030_b0250","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0962-8924(00)01856-0","article-title":"The molecular basis of T helper 1 and T helper 2 cell differentiation","volume":"10","author":"O'Garra","year":"2000","journal-title":"Trends Cell Biol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17315943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X17315943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:24:14Z","timestamp":1759400654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X17315943"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":50,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S0264410X17315943"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2017.11.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}